Cover Image
市場調查報告書

葡萄膜黑色素瘤:全球臨床實驗趨勢

Uveal Melanoma Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 329832
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
葡萄膜黑色素瘤:全球臨床實驗趨勢 Uveal Melanoma Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 70 Pages
簡介

本報告提供葡萄膜黑色素瘤治療藥的臨床試驗相關基本資料和數據,提供您各地區,各階段,各進展狀況的實施數量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關的臨床試驗之進展,有潛力的藥劑比較等資訊。

簡介

  • 葡萄膜黑色素瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲主5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量

G7各國臨床實驗數量:黑色素瘤腫瘤治療藥臨床實驗上葡萄膜的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

葡萄膜黑色素瘤治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Eli Lilly and Company
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Spectrum Pharmaceuticals, Inc.
    • Polaris Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Charite - Universitatsmedizin Berlin
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Thomas Jefferson University
    • Case Comprehensive Cancer Center
    • Radboud University
    • The Clatterbridge Cancer Centre NHS Foundation Trust
    • Alberta Health Services
    • Barnes Retina Institute

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2623CTIDB

GlobalData's clinical trial report, "Uveal Melanoma Global Clinical Trials Review, H1, 2015" provides data on the Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveal Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uveal Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Uveal Melanoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Uveal Melanoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Uveal Melanoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Uveal Melanoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Spectrum Pharmaceuticals, Inc.
      • Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
      • Polaris Pharmaceuticals, Inc.
      • Clinical Trial Overview of Polaris Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • The Clatterbridge Cancer Centre NHS Foundation Trust
      • Clinical Trial Overview of The Clatterbridge Cancer Centre NHS Foundation Trust
      • Alberta Health Services
      • Clinical Trial Overview of Alberta Health Services
      • Barnes Retina Institute
      • Clinical Trial Overview of Barnes Retina Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Uveal Melanoma Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Uveal Melanoma Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Uveal Melanoma Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Polaris Pharmaceuticals, Inc., 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Clatterbridge Cancer Centre NHS Foundation Trust, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2015*

List of Figures

  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top